MedPath

Phase II study of radiation therapy for isolated para-aoritc lymph node recurrence in patients with uterine cervical carcinoma

Phase 2
Conditions
uterine cervical carcinoma
Registration Number
JPRN-UMIN000000904
Lead Sponsor
Kitasato Gynecologic Radiation Oncology Group: KGROG
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
Female
Target Recruitment
22
Inclusion Criteria

Not provided

Exclusion Criteria

1) active double carcinoma exept carcinoma in situ 2) severe dementia 3) continous infusion and/or intake of steroids 4) severe complications 5) severe mental disorder 6) inappropriate judged by physicians

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
3-year overall survival
Secondary Outcome Measures
NameTimeMethod
3-year progression-free survival, acute morbidity, proportion of ptorocl completion, late morbidity
© Copyright 2025. All Rights Reserved by MedPath